{
  "drug_name": "Azathioprine",
  "url": "https://wikem.org/wiki/Azathioprine",
  "scraped_at": "2026-01-10T03:00:15.109145",
  "sections": {
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Kidney_transplant_rejection_prophylaxis": {
          "text": "1-3mg/kg PO QD\nStart: 3-5mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary",
          "tables": []
        },
        "Rheumatoid_arthritis,_severe": {
          "text": "1-2.5mg/kg/day PO divided QD-bid\nStart: 1mg/kg/day PO divided QD-bid; Max: 2.5mg/kg/day; Info: after 6-8wk may increase 0.5mg/kg/day q4wk",
          "tables": []
        },
        "Crohns_Disease": {
          "text": "100-250mg PO QD\nStart: 50mg PO QD; Max: 2.5mg/kg/day; Info: for induction or remission maintenance and fistulizing disease, steroid-sparing effects",
          "tables": []
        },
        "Ulcerative_colitis": {
          "text": "100-250mg PO QD\nStart: 50mg PO QD; Max: 2.5mg/kg/day; Info: for induction or remission maintenance, steroid-sparing effects",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Kidney_transplant_rejection_prophylaxis_2": {
          "text": "1-3mg/kg PO QD\nStart: 3-5mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary",
          "tables": []
        },
        "Juvenile_idiopathic_arthritis,_severe": {
          "text": "1-2.5mg/kg/day PO divided QD-bid\nStart: 1mg/kg/day PO divided QD-bid; Max: 2.5mg/kg/day; Info: after 6-8wk may increase 0.5mg/kg/day q4wk",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: Pregnancy Category D\nLactation risk\n: possibly unsafe",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult: CrCl 10-50: decrease dose 25%; CrCl <10: decrease dose 50%; HD: give 0.25mg/kg supplement; PD: not defined\nPediatric: CrCl 10-50: decrease dose 25% or give q36h; CrCl <10: decrease dose 50% or give q48h; HD: give supplement; PD: not defined",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult: not defined; caution advised\nPediatric: not defined; caution advised",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\npregnancy (RA use)\ncaution if renal impairment\ncaution if prior alkylating agents",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "leukopenia\nthrombocytopenia\nanemia\nmyelosuppression\nimmunosuppression\ninfection\nPML\nGI hypersensitivity reaction\npancreatitis\nhepatotoxicity\nhepatic veno-occlusive disease\nlymphoma\nmalignancy\nacute febrile neutrophilic dermatosis",
          "tables": []
        },
        "Common": {
          "text": "leukopenia\nthrombocytopenia\nanemia\ninfection\nnausea\nvomiting\nanorexia\ndiarrhea\nALT, AST elevated\nmalaise\nmyalgia\nfever\nrash\nmalignancy",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 5 hours\nMetabolism: liver extensively, erythrocytes; CYP450\nExcretion: bile, urine (1-2% unchanged)",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}